← All stocks

Humacyte, Inc.

HUMA Net selling
CIK 0001818382 #3976 in the set updated 17 Sep 2026
Bought (120 mo)
$47.57M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$189.59M
$82.29K on a plan · $1.92M straight out of an exercise
Sold at will
$187.58M
80 of 90 sales
Net
−$142.02M
−$140.01M against sales at will

By person

16 insiders · 144 transactions
19.0×

Laura E. Niklason holds 19.0 times base salary in stock. $12.09M of shares against $633.61K in salary for 2025.

Salary from the company's own proxy. The shares are what Laura E. Niklason last reported holding, valued at $0.56, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Dougan Brady W
Director
$15.35M (8)
$75.54M (34)
−$60.19M
22,110,905
$12.43M
+2.7%
Niklason Laura E
President, CEO and Director
$15.35M (8)
$75.54M (34)
−$60.19M
21,506,516
$12.09M
+2.8%
Ayabudge LLC entity
10% owner
$15.23M (1)
$36.47M (11)
−$21.25M
8,191,140
$4.60M
Prichard Heather Ledbetter
Chief Operating Officer
$1.66M (6) scheduled
−$1.66M
0
$0.00
Binder Gordon M
Director
$1.13M (4)
+$1.13M
210,000
$118.02K
Sander Dale A.
CFO and Chief Corp. Dev. Off
$91.66K (3)
$304.27K (2) scheduled
−$212.61K
307,813
$172.99K
Constantino Michael T.
Director
$126.18K (8)
+$126.18K
43,950
$24.70K
Sebelius Kathleen
Director
$116.00K (2)
$28.00K (2) scheduled
+$88.00K
148,025
$83.19K
Scheessele William John
Chief Commercial Officer
$75.13K (3)
+$75.13K
22,018
$12.37K
Wallace Max N.
Director
$50.03K (2)
+$50.03K
60,540
$34.02K
Jones Keith Anthony
Director
$30.37K (3)
+$30.37K
50,000
$28.10K
Parikh Shamik J
Chief Medical Officer
$11.63K (1)
$41.15K (1) scheduled
−$29.52K
272,713
$153.26K
Green Charles Bruce
Director
$7.74K (1)
+$7.74K
8,400
$4.72K
Shukla Rajiv
Director
305,000
$171.41K
Tente William Edward
Chief Regulatory Officer
52,519
$29.52K
Lawson Jeffrey Harold
Chief Surgical Officer
7,877
$4.43K

No percentages here. This company's share count has moved by a factor of 2.2 over the window, from 125,859,496 to 277,798,105 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Jones Keith Anthony
14 Sep 2026
Director
Buy
10,000
$0.56
$5.62K
Jones Keith Anthony
20 Aug 2026
Director
Buy
10,000
$0.69
$6.93K
Jones Keith Anthony
17 Aug 2026
Director
Buy
30,000
$0.59
$17.82K
Sebelius Kathleen
19 May 2026
Director
Buy
56,818
$0.88
$50.00K
Constantino Michael T.
18 May 2026
Director
Buy
11,000
$0.89
$9.84K
Scheessele William John
14 Apr 2025
Chief Commercial Officer
Buy
6,493
$1.54
$10.00K
Parikh Shamik J
10 Apr 2025
Chief Medical Officer
Buy
7,500
$1.55
$11.63K
Sander Dale A.
10 Apr 2025
CFO and Chief Corp. Deve. Off.
Buy indirect
20,000
$1.53
$30.60K
Green Charles Bruce
8 Apr 2025
Director
Buy
6,000
$1.29
$7.74K
Sebelius Kathleen
8 Apr 2025
Director
Buy
50,000
$1.32
$66.00K
Constantino Michael T.
7 Apr 2025
Director
Buy
16,000
$1.26
$20.16K
Constantino Michael T.
4 Dec 2024
Director
Buy
4,600
$4.39
$20.18K
Dougan Brady W
19 Nov 2024
Director
Buy indirect
1,797
$4.44
$7.98K
Niklason Laura E
19 Nov 2024
President, CEO and Director
Buy
1,797
$4.44
$7.98K
Dougan Brady W
29 Aug 2024
Director
Buy indirect
1,222
$6.55
$8.00K
Niklason Laura E
29 Aug 2024
President, CEO and Director
Buy
1,222
$6.55
$8.00K
Constantino Michael T.
15 Aug 2024
Director
Buy
3,100
$6.29
$19.49K
Dougan Brady W
4 Jun 2024
Director
Buy indirect
2,362
$6.35
$15.00K
Niklason Laura E
4 Jun 2024
President, CEO and Director
Buy
2,362
$6.35
$15.00K
Dougan Brady W
3 Jun 2024
Director
Buy indirect
2,050
$7.37
$15.11K
Niklason Laura E
3 Jun 2024
President, CEO and Director
Buy
2,050
$7.37
$15.11K
Wallace Max N.
20 May 2024
Director
Buy indirect
3,990
$6.29
$25.10K
Wallace Max N.
20 May 2024
Director
Buy indirect
4,015
$6.21
$24.93K
Binder Gordon M
15 May 2024
Director
Buy
50,000
$6.78
$339.00K
Binder Gordon M
15 May 2024
Director
Buy indirect
50,000
$6.57
$328.50K
Constantino Michael T.
18 May 2023
Director
Buy
4,750
$4.18
$19.86K
Sander Dale A.
16 Dec 2022
CFO and Chief Corp. Deve. Off.
Buy indirect
20,000
$2.60
$52.00K
Dougan Brady W
15 Dec 2022
Director
Buy indirect
10,000
$2.54
$25.40K
Niklason Laura E
15 Dec 2022
President, CEO and Director
Buy
10,000
$2.54
$25.40K
Scheessele William John
13 Dec 2022
Chief Commercial Officer
Buy
5,000
$3.09
$15.45K
Dougan Brady W
15 Sep 2022
Director
Buy indirect
2,000
$4.14
$8.28K
Niklason Laura E
15 Sep 2022
President, CEO and Director
Buy
2,000
$4.14
$8.28K
Binder Gordon M
2 Sep 2022
Director
Buy
61,841
$4.40
$272.10K
Binder Gordon M
1 Sep 2022
Director
Buy
48,159
$4.00
$192.64K
Scheessele William John
24 May 2022
Chief Commercial Officer
Buy
10,525
$4.72
$49.68K
Constantino Michael T.
23 May 2022
Director
Buy
2,000
$4.83
$9.66K
Niklason Laura E
23 May 2022
President, CEO and Director
Buy
10,000
$4.83
$48.30K
Dougan Brady W
23 May 2022
Director
Buy indirect
10,000
$4.83
$48.30K
Sander Dale A.
17 May 2022
CFO and Chief Corp. Deve. Off.
Buy
2,000
$4.53
$9.06K
Constantino Michael T.
22 Nov 2021
Director
Buy
2,300
$10.79
$24.82K
Constantino Michael T.
22 Nov 2021
Director
Buy
200
$10.83
$2.17K
Ayabudge LLC
26 Aug 2021
10% owner
Buy
1,522,500
$10.00
$15.23M
Dougan Brady W
26 Aug 2021
Director
Buy indirect
1,522,500
$10.00
$15.23M
Niklason Laura E
26 Aug 2021
President, CEO and Director
Buy indirect
1,522,500
$10.00
$15.23M

What was left out

Form 4 filings counted 202
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 8
Sales at will 80
Transactions with no price 0
Shares from compensation/vesting 60,863,169
Sales filed before the plan box existed 23
History held since 23 Sep 2020